Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

08/08/2024 05:40

Aug 8 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             14.62               13.51            57.00    
                 (+8.3 pct)          (+9.2 pct)       (+2.9 pct)  
  Operating          1.15              589 mln            2.60    
                 (+95.1 pct)         (-5.2 pct)       (+32.4 pct) 
  Recurring        909 mln             658 mln            2.30    
                 (+38.2 pct)         (-15.0 pct)      (+23.1 pct) 
  Net              632 mln             479 mln            1.70    
                 (+31.9 pct)         (-14.2 pct)      (+23.4 pct) 
  EPS             74.05 yen           54.71 yen       197.43 yen  
  Ann Div                             70.00 yen        80.00 yen  
  -Q2 div                             35.00 yen        40.00 yen  
  -Q4 div                             35.00 yen        40.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T